The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Perlecan Heparan Sulfate Proteoglycan
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“coupled with numerous cell culture studies by other groups over the years (13–19, 21), argue for independent action of proteoglycans in the hepatic clearance of triglyceride-rich remnants.”
From Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice (2009) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, hepatocyte HS plays a central role in the metabolism of all subclasses of lipoproteins, with the exception of HDL, as suggested previously (25).”
From Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members (2007) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Syndecans (13–16) and perlecan (14, 17, 18) have been shown to mediate the internalization of model remnant lipoproteins or TRL preparations enriched in LPL or apoE.”
From Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice (2009) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“Thus, we believe that the genetic data presented here and previously (9), coupled with numerous cell culture studies by other groups over the years (13–19, 21), argue for independent action of proteoglycans in the hepatic”
From Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice (2009) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., & Ornitz, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90512-w · Cited by 2,440
Rohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1240 · Cited by 455
Mulder, M., Lombardi, P., Jansen, H., van Berkel, T. J., Frants, R. R., & Havekes, L. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98359-6 · Cited by 214
Ji, Z. S., Fazio, S., & Mahley, R. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36849-7 · Cited by 138
Research works printed but not linked: 80
- Fuki, 1996, Circulation, 94 Suppl. I, 698
- David, 1993, FASEB J., 7, 1023, 10.1096/fasebj.7.11.8370471 · DOI
- Rosenberg, 1997, J. Clin. Invest., 99, 2062, 10.1172/JCI119377 · DOI
- Williams, 1997, Curr. Opin. Lipidol., 8, 252, 10.1097/00041433-199706000-00013 · DOI
- Rapraeger, 1998, Curr. Opin. Cell Biol., 10, 620, 10.1016/S0955-0674(98)80038-0 · DOI
- Woods, 1998, Trends Cell Biol., 8, 189, 10.1016/S0962-8924(98)01244-6 · DOI
- Bernfield, 1999, Annu. Rev. Biochem., 68, 729, 10.1146/annurev.biochem.68.1.729 · DOI
- Mahley, 1999, J. Lipid Res., 40, 1, 10.1016/S0022-2275(20)33334-4 · DOI · Paper page
- Chappell, 1993, J. Biol. Chem., 268, 14168, 10.1016/S0021-9258(19)85223-7 · DOI
- Beisiegel, 1994, Ann. N. Y. Acad. Sci., 737, 53, 10.1111/j.1749-6632.1994.tb44301.x · DOI
- Mahley, 1994, Ann. N. Y. Acad. Sci., 737, 39, 10.1111/j.1749-6632.1994.tb44300.x · DOI
- Rapraeger, 1991, Science, 252, 1705, 10.1126/science.1646484 · DOI · Paper page
- Yanagishita, 1992, J. Biol. Chem., 267, 9505, 10.1016/S0021-9258(19)50119-3 · DOI · Paper page
- Liu, 1998, J. Biol. Chem., 273, 22825, 10.1074/jbc.273.35.22825 · DOI
- Williams, 1991, Circulation, 84, Suppl. II, 566
- Williams, 1992, J. Biol. Chem., 267, 13284, 10.1016/S0021-9258(18)42208-9 · DOI · Paper page
- Eisenberg, 1992, J. Clin. Invest., 90, 2013, 10.1172/JCI116081 · DOI
- Rumsey, 1992, J. Clin. Invest., 90, 1504, 10.1172/JCI116018 · DOI
- Ji, 1993, J. Biol. Chem., 268, 10160, 10.1016/S0021-9258(18)82186-X · DOI · Paper page
- Ji, 1994, J. Biol. Chem., 269, 13429, 10.1016/S0021-9258(17)36850-3 · DOI
- Mortimer, 1995, J. Biol. Chem., 270, 28767, 10.1074/jbc.270.48.28767 · DOI
- Ji, 1995, J. Lipid Res., 36, 583, 10.1016/S0022-2275(20)39892-8 · DOI
- Mann, 1995, J. Lipid Res., 36, 517, 10.1016/S0022-2275(20)39885-0 · DOI · Paper page
- Windler, 1996, Hepatology, 24, 344, 10.1002/hep.510240210 · DOI
- Fuki, 1997, J. Clin. Invest., 100, 1611, 10.1172/JCI119685 · DOI · Paper page
- Fuki, I. V., Meyer, M. E., and Williams, K. J. (2000)Biochem. J., in press
- Noonan, 1991, J. Biol. Chem., 266, 22939, 10.1016/S0021-9258(18)54445-8 · DOI
- Iozzo, 1994, Biochem. J., 302, 625, 10.1042/bj3020625 · DOI
- Hayashi, 1992, J. Cell Biol., 119, 945, 10.1083/jcb.119.4.945 · DOI
- Battaglia, 1993, Eur. J. Cell Biol., 61, 92
- Rescan, 1993, Am. J. Pathol., 142, 199
- Handler, 1997, Dev. Dyn., 210, 130, 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H · DOI
- Roskams, 1995, Hepatology, 21, 950, 10.1002/hep.1840210410 · DOI
- Evanko, 1998, Am. J. Pathol., 152, 533
- Socorro, 1985, Prep. Biochem., 15, 133
- Saxena, 1989, J. Biol. Chem., 264, 4349, 10.1016/S0021-9258(18)83748-6 · DOI
- Sivaram, 1992, J. Biol. Chem., 267, 16517, 10.1016/S0021-9258(18)42033-9 · DOI
- Goldstein, 1983, Methods Enzymol., 98, 241, 10.1016/0076-6879(83)98152-1 · DOI
- Jentoft, 1983, Methods Enzymol., 91, 570, 10.1016/S0076-6879(83)91052-2 · DOI
- Lund-Katz, 1988, J. Biol. Chem., 263, 13831, 10.1016/S0021-9258(18)68319-X · DOI
- Strickland, 1991, J. Biol. Chem., 266, 13364, 10.1016/S0021-9258(18)98848-4 · DOI
- Willnow, 1992, J. Biol. Chem., 267, 26172, 10.1016/S0021-9258(18)35732-6 · DOI
- Williams, 1992, J. Biol. Chem., 267, 9035, 10.1016/S0021-9258(19)50384-2 · DOI · Paper page
- Chen, 1987, Cancer Genet. Cytogenet., 27, 125, 10.1016/0165-4608(87)90267-6 · DOI
- Iozzo, 1984, J. Cell Biol., 99, 403, 10.1083/jcb.99.2.403 · DOI
- Iozzo, 1987, J. Biol. Chem., 262, 1888, 10.1016/S0021-9258(19)75723-8 · DOI
- Dodge, 1990, J. Biol. Chem., 265, 18023, 10.1016/S0021-9258(18)38265-6 · DOI
- Esko, 1991, Curr. Opin. Cell Biol., 3, 805, 10.1016/0955-0674(91)90054-3 · DOI
- Lidholt, 1992, Proc. Natl. Acad. Sci. U. S. A., 89, 2267, 10.1073/pnas.89.6.2267 · DOI
- Williams, 1991, J. Clin. Invest., 88, 1300, 10.1172/JCI115434 · DOI
- Tabas, 1993, J. Biol. Chem., 268, 20419, 10.1016/S0021-9258(20)80745-5 · DOI
- Akiyama, 1987, J. Biol. Chem., 262, 5592, 10.1016/S0021-9258(18)45614-1 · DOI
- Miranda, 1974, J. Cell Biol., 62, 406, 10.1083/jcb.62.2.406 · DOI
- Weigel, 1982, J. Biol. Chem., 257, 1201, 10.1016/S0021-9258(19)68175-5 · DOI
- Luton, 1994, J. Immunol., 153, 63, 10.4049/jimmunol.153.1.63 · DOI
- Markwell, 1978, Anal. Biochem., 87, 206, 10.1016/0003-2697(78)90586-9 · DOI
- Sege, 1986, Mol. Cell. Biol., 6, 3268
- FitzGerald, 1995, J. Cell Biol., 129, 1533, 10.1083/jcb.129.6.1533 · DOI
- Khoo, 1988, Arteriosclerosis, 8, 348, 10.1161/01.ATV.8.4.348 · DOI
- Seo, 1997, J. Lipid Res., 38, 765, 10.1016/S0022-2275(20)37243-6 · DOI
- Al-Haideri, 1997, Biochemistry, 36, 12766, 10.1021/bi9631024 · DOI
- Tumova, 1997, J. Biol. Chem., 272, 9078, 10.1074/jbc.272.14.9078 · DOI
- Yanagishita, 1984, J. Biol. Chem., 259, 10270, 10.1016/S0021-9258(18)90960-9 · DOI
- Ji, 1994, Arterioscler. Thromb., 14, 2025, 10.1161/01.ATV.14.12.2025 · DOI
- Chen, 1990, J. Biol. Chem., 265, 3116, 10.1016/S0021-9258(19)39742-X · DOI · Paper page
- O'Toole, 1995, J. Biol. Chem., 270, 8553, 10.1074/jbc.270.15.8553 · DOI
- Suits, 1989, Proc. Natl. Acad. Sci. U. S. A., 86, 2713, 10.1073/pnas.86.8.2713 · DOI
- Iozzo, 1997, J. Biol. Chem., 272, 5219, 10.1074/jbc.272.8.5219 · DOI
- Sharma, 1998, J. Biol. Chem., 273, 4642, 10.1074/jbc.273.8.4642 · DOI
- Garcia de Yebenes, 1999, J. Neurochem., 73, 812, 10.1046/j.1471-4159.1999.0730812.x · DOI
- Brown, 1999, J. Biol. Chem., 274, 7111, 10.1074/jbc.274.11.7111 · DOI
- Kim, 1997, Proc. Soc. Exp. Biol. Med., 214, 123, 10.3181/00379727-214-44078 · DOI
- Molist, 1998, Eur. J. Biochem., 254, 371, 10.1046/j.1432-1327.1998.2540371.x · DOI
- Spady, 1992, Semin. Liver Dis., 12, 373, 10.1055/s-2008-1040407 · DOI · Paper page
- Panzenboeck, 1997, J. Lipid Res., 38, 239, 10.1016/S0022-2275(20)37437-X · DOI
- Ji, 1997, J. Biol. Chem., 272, 31285, 10.1074/jbc.272.50.31285 · DOI · Paper page
- Tabas, 1991, J. Cell Biol., 115, 1547, 10.1083/jcb.115.6.1547 · DOI
- Reiland, 1993, J. Cell Sci., 105, 1085, 10.1242/jcs.105.4.1085 · DOI
- Quarto, 1994, J. Cell Sci., 107, 3201, 10.1242/jcs.107.11.3201 · DOI
- Gleizes, 1995, Eur. J. Cell Biol., 66, 47
Cited by
Sorted by citations
Stanford, K. I., Bishop, J. R., Foley, E. M., Gonzales, J. C., Niesman, I. R., Witztum, J. L., & Esko, J. D. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38251 · Cited by 226
MacArthur, J. M., Bishop, J. R., Stanford, K. I., Wang, L., Bensadoun, A., Witztum, J. L., & Esko, J. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29154 · Cited by 216
Circadian control of heparan sulfate levels times phagocytosis of amyloid beta aggregates
Clark, G. T., Yu, Y., Urban, C. A., Fu, G., Wang, C., Zhang, F., Linhardt, R. J., & Hurley, J. M. (2022) · PLOS Genetics · doi:10.1371/journal.pgen.1009994 · Cited by 31
Metadata
- Authors
- Fuki, I. V., Iozzo, R. V., & Williams, K. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 275
- Issue
- 33
- Pages
- 25742-25750
- ISSN
- 0021-9258
- Cited by
- 95
- References
- 5
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
